MARKET WIRE NEWS
  1. Home
  2. Stock
  3. PRLD
  4. News
PRLD
Quote
Short
News
Articles
Message Board

Prelude Therapeutics Incorporated (NASDAQ : PRLD ) News

Prelude Therapeutics Incorporated (NASDAQ: PRLD) News Releases

PRLD News Releases
PRLD : NASDAQ
US Earnings Reports
Expected US Company Earnings on Monday, March 9th, 2026
PRLD : NASDAQ
Baystreet
The FDA Cleared 50 Oncology Approvals in 2025 and the Pipeline Keeps Accelerating
PRLD : NASDAQ
GlobeNewswire
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
PRLD : NASDAQ
SeekingAlpha
Prelude climbs as FDA clears study for Incyte-partnered cancer candidate
PRLD : NASDAQ
GlobeNewswire
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
PRLD : NASDAQ
GlobeNewswire
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
PRLD : NASDAQ
SeekingAlpha
Tracking Baker Brothers Portfolio - Q3 2025 Update
PRLD : NASDAQ
GlobeNewswire
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
PRLD : NASDAQ
Financial News Media
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
PRLD : NASDAQ
SeekingAlpha
Prelude Therapeutics Incorporated (PRLD) Q3 2025 Earnings Call Transcript

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.